NO980071D0 - Bruk av ufordöyelige oligosakkarider for å behandle og forhindre otitis media hos mennesker - Google Patents

Bruk av ufordöyelige oligosakkarider for å behandle og forhindre otitis media hos mennesker

Info

Publication number
NO980071D0
NO980071D0 NO980071A NO980071A NO980071D0 NO 980071 D0 NO980071 D0 NO 980071D0 NO 980071 A NO980071 A NO 980071A NO 980071 A NO980071 A NO 980071A NO 980071 D0 NO980071 D0 NO 980071D0
Authority
NO
Norway
Prior art keywords
humans
treat
otitis media
indigestible oligosaccharides
prevent otitis
Prior art date
Application number
NO980071A
Other languages
English (en)
Norwegian (no)
Other versions
NO980071L (no
Inventor
Margaret Ione Halpin Dohnalek
Karin Margaret Ostrom
Milo Duane Hilty
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO980071L publication Critical patent/NO980071L/no
Publication of NO980071D0 publication Critical patent/NO980071D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G3/368Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/20Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/203Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Dairy Products (AREA)
  • Medicines Containing Plant Substances (AREA)
NO980071A 1995-07-10 1998-01-07 Bruk av ufordöyelige oligosakkarider for å behandle og forhindre otitis media hos mennesker NO980071D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US100095P 1995-07-10 1995-07-10
US08/653,083 US5849324A (en) 1995-07-10 1996-06-12 Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
PCT/US1996/011243 WO1997002830A2 (fr) 1995-07-10 1996-07-02 Utilisation d'oligosaccharides non digestibles dans le traitement et la prevention de l'otite moyenne chez l'homme

Publications (2)

Publication Number Publication Date
NO980071L NO980071L (no) 1998-01-07
NO980071D0 true NO980071D0 (no) 1998-01-07

Family

ID=26668400

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980071A NO980071D0 (no) 1995-07-10 1998-01-07 Bruk av ufordöyelige oligosakkarider for å behandle og forhindre otitis media hos mennesker

Country Status (17)

Country Link
US (1) US5849324A (fr)
EP (1) EP0837686B1 (fr)
JP (1) JP2002502357A (fr)
AR (1) AR002771A1 (fr)
AT (1) ATE225662T1 (fr)
AU (1) AU719547B2 (fr)
BR (1) BR9609619A (fr)
CA (1) CA2226420A1 (fr)
DE (1) DE69624243T2 (fr)
DK (1) DK0837686T3 (fr)
ES (1) ES2186788T3 (fr)
IL (1) IL122735A0 (fr)
MX (1) MX9800331A (fr)
NO (1) NO980071D0 (fr)
NZ (1) NZ312022A (fr)
PT (1) PT837686E (fr)
WO (1) WO1997002830A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
DE19817877C2 (de) * 1998-04-22 2002-06-13 Hans Guenter Berner Energy-Drink auf Fruchtsaftbasis
AT411958B8 (de) 1998-11-19 2004-09-27 Jhs Privatstiftung Erfrischungsgetränk zur steigerung der alkohol-abbau-kapazität
US6630452B2 (en) 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
CN1229115C (zh) * 2000-02-17 2005-11-30 惠氏公司 含有益生素物质的营养配方
US8642051B2 (en) 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
CA2439293A1 (fr) 2001-03-05 2002-09-12 Stephen P. Ernest Formulation enterale
EP1243273A1 (fr) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition contenant un agent prebiotique pour le traitement d'inflammation et d'activation anormal des agents immunitaires non-spécifiques
AU2003282494A1 (en) * 2002-10-11 2004-05-04 Wyeth Nutritional formulations containing synbiotic substances
US7867541B2 (en) * 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
US7951410B2 (en) * 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
EP1811864B1 (fr) * 2004-11-12 2008-05-14 N.V. Nutricia Aliment de transition nutritionnelle liquide pour nourrissons
FR2894827B1 (fr) * 2005-12-21 2010-10-29 Galderma Res & Dev Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation,et leurs utilisations
EP1886680A1 (fr) * 2006-05-23 2008-02-13 Nestec S.A. Supplément pour futures mamans
US20090297660A1 (en) * 2008-06-02 2009-12-03 Kraft Food Holdings, Inc. Cheese Products Containing Galacto-Oligosaccharides And Having Reduced Lactose Levels
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB978170A (en) * 1961-08-04 1964-12-16 Koninklijke Gist Spiritus Process for the preparation of water-soluble derivatives of polyene antibiotics
GB2072679B (en) * 1980-03-31 1983-11-09 Meiji Seika Kaisha Sweetener
CA1324529C (fr) * 1987-09-15 1993-11-23 Tatsuhiko Kan Aliment liquide comprenant de la polydextrose et des oligosaccharides
JPH02178229A (ja) * 1988-12-28 1990-07-11 Fujirebio Inc 抗ウイルス剤
US5219842A (en) * 1989-08-29 1993-06-15 Nihon Shokuhin Kako Co., Ltd. Method of improving intestinal floras
US5021245A (en) * 1990-05-22 1991-06-04 Abbott Laboratories Infant formula containing a soy polysaccharide fiber source
US5206355A (en) * 1991-09-30 1993-04-27 The University Of Montana Preparation of trisaccharides (kestoses) and polymers by pyrolysis of amorphous sucrose
JP2654529B2 (ja) * 1992-03-27 1997-09-17 大塚製薬株式会社 健康飲料組成物
US5318794A (en) * 1992-12-02 1994-06-07 The University Of Montana Process for producing caramel having a high content of fructose oligosaccharides and caramel product produced thereby
US5439893A (en) * 1993-05-26 1995-08-08 University Of Montana Methods for the treatment and prevention of diarrhea
JPH0725772A (ja) * 1993-07-09 1995-01-27 Japan Atom Energy Res Inst 放射線処理による多糖類からの抗菌活性物質及びその製造方法

Also Published As

Publication number Publication date
WO1997002830A3 (fr) 1997-04-10
DE69624243T2 (de) 2003-07-03
WO1997002830A2 (fr) 1997-01-30
ES2186788T3 (es) 2003-05-16
CA2226420A1 (fr) 1997-01-30
NO980071L (no) 1998-01-07
IL122735A0 (en) 1998-08-16
ATE225662T1 (de) 2002-10-15
AU719547B2 (en) 2000-05-11
NZ312022A (en) 2000-06-23
US5849324A (en) 1998-12-15
DK0837686T3 (da) 2003-02-10
BR9609619A (pt) 1999-04-06
MX9800331A (es) 1998-07-31
PT837686E (pt) 2003-02-28
AU6345296A (en) 1997-02-10
DE69624243D1 (de) 2002-11-14
EP0837686B1 (fr) 2002-10-09
AR002771A1 (es) 1998-04-29
JP2002502357A (ja) 2002-01-22
EP0837686A2 (fr) 1998-04-29

Similar Documents

Publication Publication Date Title
NO980083D0 (no) Anvendelse av ufordöyelige oligosakkarider for å forebygge og behandle diaré
NO980071D0 (no) Bruk av ufordöyelige oligosakkarider for å behandle og forhindre otitis media hos mennesker
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
NO972412L (no) Antiparasitt-preparat for å behandle og beskytte kjæledyr
PL326653A1 (en) Application of epinastin in pain relieving treatments
EP0925046A4 (fr) Formulations topiques et methodes de traitement des douleurs hemorroidales
NO975331D0 (no) Anvendelse av R-enantiomer av N-propargyl-1-aminoindan salter og sammensetninger derav
IL117993A0 (en) Modified anti-icam-1 antibodies and their use in the treatment of inflammation
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
NO980687L (no) System og fremgangsmåte for perfusjon-hypertermibehandling
PT767666E (pt) Metodos e composicoes uteis em profilaxia e em terapia de problemas relacionados com endotoxemia
PL332579A1 (en) Application of 1-hydroxy-2-pyridinones in treating dermatological infections
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
NO971705D0 (no) Fremgangsmåte for å minimalisere opplösningsmiddel-degradering og korrosjon i systemer for behandling av aminopplösningsmiddel
FI971584A7 (fi) Estävä ja hoitava aine tyypin I allergiatauteja varten
AUPN694895A0 (en) Desalting and purification of oligosaccharides and their derivatives
NO982100D0 (no) Peptid-derivater av Dolastatin 15 og deres anvendelse
NO976024D0 (no) Anvendelse av N-cykloheksylbenzamider for å behandle tarmlidelser
HK1010487A (en) Use of indigestible oligosaccharides to treat and prevent otitis media in humans
ZA965619B (en) Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
HK1010488A (en) Use of indigestible oligosaccharides to prevent and treat diarrhea
ZA965904B (en) Use of indigestible oligosaccharides to prevent gastroin-testinal infections and reduce duration of diarrhea in humans
AU7614296A (en) Desalting and purification of oligosaccharides and their derivatives
IT238825Y1 (it) Guanciale anatomico cervicale per prevenire e trattare i disturbidella c.v. cervicale
NO944386D0 (no) Fremstilling og anvendelse av tetrazolderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application